Synthesis, Identification and Molecular Docking Evaluation of Novel Sulfonamide-Levofloxacin Targeting Pseudomonas aeruginosa
Abstract
Background: Pseudomonas aeruginosa is a Gram-negative rod-shaped bacterium that can be found in diverse environments and causes severe infections in immunocompromised patients and burn victims. Because of its extensive antibiotic resistance, effective eradication of Pseudomonas aeruginosa is still a significant therapeutic issue. Objective: This study was to improve the bactericidal activity of levofloxacin through structural modification. Methodology: Fifty clinical samples were collected. From May 2025 to August 2025, 50 samples were taken from Al-Yarmouk Hospital, including urine, mouth, and wound samples. Sixteen of these were identified as P. aeruginosa. Levofloxacin and its synthetic derivatives were assayed against these isolates at concentrations of 25, 50, and 100 μg/mL. A new series of sulfonamide derivativesA1,B1 were synthesized using the levofloxacin scaffold through the Hinsberg reaction and characterized using FT-IR and ¹H-NMR. Results: Molecular docking results showed strong binding affinities of the derivatives toward bacterial topoisomerase. Conclusion: Levofloxacin showed the highest binding energy (–12.522 kcal/mol), while the methyl and nitro analogs exhibited favorable hydrogen bonding with GLU474, GLU475, and ARG456, indicating promising antibacterial potential. Bangladesh Journal of Infectious Diseases, June 2026;13(1):308-318
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.